Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
28th April 2026 Uncategorised 0Novartis CEO Vas Narasimhan says that Europe needs a “complete rethink” on how it prices its drugs, warning that the entrance of new pharmaceuticals into its markets could be delayed.
More: Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
Source: fierce
